Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride
- Conditions
- Interventions
- First Posted Date
- 2009-02-16
- Last Posted Date
- 2010-10-19
- Lead Sponsor
- Ineos Healthcare Limited
- Target Recruit Count
- 1000
- Registration Number
- NCT00844662
- Locations
- πΊπΈ
Cleveland William MD, Atlanta, Georgia, United States
πΊπΈDiagnostic Clinic of Houston, Houston, Texas, United States
πΊπΈSouthWest Houston Research LTD., Houston, Texas, United States
Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate
- Conditions
- Interventions
- First Posted Date
- 2009-02-11
- Last Posted Date
- 2010-10-19
- Lead Sponsor
- Ineos Healthcare Limited
- Target Recruit Count
- 657
- Registration Number
- NCT00841126
- Locations
- π¨π¦
William Osler Health Centre, Brampton, Ontario, Canada
πΊπΈTidewater Kidney Specialists, Virginia Beach, Virginia, United States
π¦πΊRoyal Adelaide Hospital, Adelaide, South Australia, Australia
Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia
- First Posted Date
- 2007-02-19
- Last Posted Date
- 2009-08-10
- Lead Sponsor
- Ineos Healthcare Limited
- Target Recruit Count
- 64
- Registration Number
- NCT00436683
- Locations
- π¬π§
Renal Unit, St Bartholomew's Hospital, West Smithfield, London, United Kingdom
π¬π§Renal Dialysis Unit, Gartnavel General Hospital, Glasgow, United Kingdom
π¬π§Renal Dialysis Unit, Western Infirmary, Dumbarton Road, Glasgow, United Kingdom
An Evaluation of the Long-term Safety of Magnesium Iron Hydroxycarbonate
- First Posted Date
- 2006-08-01
- Last Posted Date
- 2009-08-10
- Lead Sponsor
- Ineos Healthcare Limited
- Target Recruit Count
- 44
- Registration Number
- NCT00358722
- Locations
- π¬π§
Renal Unit, Leicester General Hospital, Leicester, United Kingdom
πΊπΈ1614 West 42nd Street, Pine Bluff, Arkansas, United States
π¬π§General Medicine and Nephrology, Norfolk and Norwich University Hospital, Norwich, United Kingdom
Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients
- First Posted Date
- 2006-04-25
- Last Posted Date
- 2009-08-10
- Lead Sponsor
- Ineos Healthcare Limited
- Target Recruit Count
- 111
- Registration Number
- NCT00317694
- Locations
- π¬π§
Nottingham Renal and Transplant Unit, Nottingham City Hospital, Nottingham, United Kingdom
π¬π§Richard Bright Renal Unit, Southmead Hospital, Bristol, United Kingdom
π¬π§Dialysis Unit, Broad Green Hospital, Liverpool, United Kingdom